Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Commonalities"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
dewey-ones:"610 - Medicine & health"
Search alternatives
:
commonalities »
communities
,
commodities
Showing
21
-
40
of
590
Search:
'"Commonalities"'
,
query time: 0.05s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
21
Fentanyl (Fentora)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
22
Ledipasvir/Sofosbuvir (Harvoni) : for the treatment of chronic hepatitis C virus (CHC) G1 infection in adults
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
23
Rotigotine (Neupro) (Transdermal patch)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
24
Elosulfase alfa (Vimizim)
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
25
Lomitapide (Juxtapid)
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
26
CDEC final recommendation: Dolutegravir (Tivicay -- ViiV Healthcare ULC) : indication : HIV infection
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
27
Aripiprazole prolonged release suspension for injection (Abilify maintena) (300 mg and 400 mg vial)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
28
Glycerol phenylbutyrate (Ravicti)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
29
CADTH Canadian Drug Expert Committee final recommendation: Ticagrelor (Brilinta -- AstraZeneca Canada Inc.) indication : secondary prevention of atherothrombotic events
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
30
Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (EVG/COBI/FTC/TAF) (Genvoya) fixed-dose combination, oral tablet
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
31
Simeprevir (Galexos) (150 mg)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
32
Alogliptin (Nesina) for type 2 diabetes mellitus
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
33
CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
34
Galsulfase (Naglazyme)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
35
Ustekinumab (Stelara)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
36
Mepolizumab (Nucala)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
37
Omalizumab (Xolair) : treatment of adults and adolescents (12 years of age and above) with chronic idiopathic urticaria
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
38
CADTH Canadian Drug Expert Committee final recommendation: Tesamorelin (Egrifta -- Theratechnologies Inc.) indication : HIV-associated lipohypertherapy
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
39
Rifaximin (Zaxine) : for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in patients > 18 years of age
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
40
Brivaracetam (Brivlera)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
1
2
3
4
5
6
7
8
9
10
11
Back
Narrow Search
Remove Filters
Clear Filter
Classification: 610 - Medicine & health
Year of Publication
From:
To:
Classification
610 - Medicine & health
330 - Economics
128
140 - Specific philosophical schools
28
700 - The arts; fine & decorative arts
27
380 - Commerce, communications & transportation
2
580 - Plants (Botany)
2
Language
English
590
Collection
National Center for Biotechnology Information
581
Springer Book Archives -2004
8
Cambridge Books Online
1
Author
Canadian Agency for Drugs and Technologies in Health
530
CADTH Canadian Drug Expert Committee
199
Canadian Diabetes Association
2
Archer, A.R.
1
Brooks, D.
1
Chapman, C.
1
more ...
Cornell, M.N.
1
Dunbar, Edward M.
1
Fowler, T.
1
Frischmann, Brett M.
1
Fry, John
1
Fry, L.
1
Gambrill, E.
1
Jariwalla, G.
1
Lancaster-Smith, M.
1
Madison, Michael J.
1
Marsden, P.
1
Martin, A.
1
May, R.
1
McCullagh, A.G.
1
Strandburg, Katherine Jo
1
Wharton, C.F.
1
see all ...
less ...
Recently Uploaded
Last Month
57
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=2&filter%5B%5D=dewey-ones%3A%22610+-+Medicine+%26+health%22&lookfor=%22Commonalities%22&type=Series
Send by Email
×
Loading...